pieris.com (PIRS): Prakiraan wutah bathi resik saben saham kanggo taun ngarep
Pieris Pharmaceuticals (PIRS) relies on patented protein scaffolds for long-term B2B contracts. Innovative cancer and lung treatments are forming the foundation of future medicine. However, the company is currently cutting costs and seeking new strategies due to a lack of cash flows. The annual EPS forecast demonstrates volatility, with the metric standing at -27.50, necessitating caution when analyzing expected earnings.
Rincian metrik lan analitis perusahaan Pieris Pharmaceuticals Inc (PIRS)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- rincian nilai buku perusahaan:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Pieris Pharmaceuticals|PIRS - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Pieris|PIRS - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Pieris Pharma|PIRS - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Pieris Pharmaceuticals|Indikator likuiditas cepet pieris.com
- data bathi resik lan rasio valuasi:
PIRS - Bathi pungkasan|Bathi sing dikarepake Pieris Pharmaceuticals|PIRS - Kapitalisasi marang bathi resik|Pangali Forward P/E Pieris Pharmaceuticals, Inc.|PIRS - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Pieris Pharmaceuticals, Inc.|PIRS - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Pieris Pharmaceuticals|PIRS - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan pieris.com|PIRS - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Pieris Pharmaceuticals
- indikator pendapatan dodolan lan penghasilan bisnis:
Pambiji fundamental perusahaan:pieris.com, PIRS
This indicator reflects the consensus forecast for next year's earnings growth, filtering out short-term market noise to identify the true trajectory of institutional capital. By analyzing the forward-looking assessment of net income dynamics, investors can gauge the sensitivity of Pieris Pharmaceuticals (PIRS) valuation to the commercialization of unique anticalin proteins, which establish a high patent barrier and determine the company's attractiveness for strategic partnerships with big pharma behemoths.
Analisis pesaing
Prakiraan wutah bathi resik saben saham kanggo taun ngarep Haleon plc|Prakiraan wutah bathi resik saben saham ing taun ngarep kenvue.com KVUE|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Verona Pharma (VRNA)|MENS (Jyong Biotech Limited) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Ligand Pharma LGND|Prakiraan wutah bathi kanggo taun ngarep Amneal Corp AMRX|Perrigo Company PLC - Prakiraan wutah bathi kanggo taun ngarep|ALVO: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|liquidia.com (LQDA) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|GLPG (Galapagos) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep ANIP|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep MNKD (Afrezza)|Prakiraan wutah bathi kanggo taun ngarep AMPH|PCRX (Pacira BioSciences) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Aquestive Corp - Prakiraan wutah bathi kanggo taun ngarep|scpharmaceuticals.com (SCPH) - Prakiraan wutah bathi saben saham kanggo taun ngarep|TECX: Prakiraan wutah bathi kanggo taun ngarep|Tonix Pharmaceuticals - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep SXTC|EPRX: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep BHST (BioHarvest Sciences Inc.)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Invizyne|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Oramed Pharmaceuticals ORMP|Dinamika bathi saben saham sing diarepake ing taun ngarep ENTX|HYFT - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep ABVC (ABVC BioPharma Inc.)|CPIX: Prakiraan wutah bathi kanggo taun ngarep|Quantum BioPharma Limited - Dinamika bathi saben saham sing diarepake ing taun ngarep|FGEN (FibroGen Corp) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Telomir Pharmaceuticals|Prakiraan wutah bathi kanggo taun ngarep RANI|SNYR (Synergy CHC Corp.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep RLYB (Rallybio Corp)|LEXX: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|PULM - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|PTHL: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|APM (aptorumgroup.com) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Lyra Therapeutics - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep YCBD|PRFX: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep altamiratherapeutics.com CYTO|Prakiraan wutah bathi kanggo taun ngarep Lipella Pharmaceuticals Inc LIPO|OPTN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Procaps Group Corp (PROC) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Petros (PTPI) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep QLI (Qilian International)|Prakiraan wutah bathi saben saham kanggo taun ngarep SLRN|TFF Pharmaceuticals, Inc. - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep
